| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/02/2002 | WO2001062923A3 Transporters and ion channels |
| 05/02/2002 | WO2001062794A3 18607, a human calcium channel |
| 05/02/2002 | WO2001061009A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001061008A3 Polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001060317A3 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250 |
| 05/02/2002 | WO2001060162A3 Cationic, amphipathic beta-sheet peptides and uses thereof |
| 05/02/2002 | WO2001058957A3 Enhancing the circulating half-life of antibody-based fusion proteins |
| 05/02/2002 | WO2001057189A3 Fas pathway genes |
| 05/02/2002 | WO2001055393A3 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 05/02/2002 | WO2001055332A3 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| 05/02/2002 | WO2001055314A3 Digestive system related nucleic acids, proteins and antibodies |
| 05/02/2002 | WO2001055210A3 Human cyr61 |
| 05/02/2002 | WO2001053455A3 Novel nucleic acids and polypeptides |
| 05/02/2002 | WO2001053454A3 Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides |
| 05/02/2002 | WO2001051635A3 Novel stra6 polypeptides |
| 05/02/2002 | WO2001048209A3 Genes identified as required for proliferation of e. coli |
| 05/02/2002 | WO2001048185A3 Transcription regulatory sequences derived from chlamydomonas reinhardtii |
| 05/02/2002 | WO2001044287A3 Novel polypeptides and nucleic acids encoding same |
| 05/02/2002 | WO2001040301A3 A gene, disrupted in schizophrenia |
| 05/02/2002 | WO2001038394A3 Polypetptides and methods for thymic vaccination |
| 05/02/2002 | WO2001034824A3 Methods and compositions comprising renilla gfp |
| 05/02/2002 | WO2001034767A3 22 human secreted proteins |
| 05/02/2002 | WO2001029071A3 Genes associated with obesity and methods for using the same |
| 05/02/2002 | WO2001029070A3 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 05/02/2002 | WO2001027292A3 Methods and compositions for targeting a cell |
| 05/02/2002 | WO2001025255A3 Novel zinc finger protein |
| 05/02/2002 | WO2001023538A3 Molecules for disease detection and treatment |
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2001018061A3 Maize polynucleotides and related polypeptides useful for enhancing disease resistance in crop plants |
| 05/02/2002 | WO2001018031A3 Peptides and pharmaceutical compositions comprising same |
| 05/02/2002 | WO2001005997A9 Method for production of tetanus toxin using media substantially free of animal products |
| 05/02/2002 | WO2001005803A9 NOVEL cDNAs ASSOCIATED WITH RENAL DISEASE |
| 05/02/2002 | WO2001004283A9 Organic anion transporter genes and proteins |
| 05/02/2002 | WO2001000874A3 Cancer associated antigens and uses therefor |
| 05/02/2002 | WO2001000237A9 Synthetic peptide immunogens and antibodies thereto |
| 05/02/2002 | WO2000078972A3 Regulation with binding cassette transporter protein abc1 |
| 05/02/2002 | WO2000078960A9 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/02/2002 | WO2000077208A9 Gustatory receptors in drosophila |
| 05/02/2002 | WO2000044395A9 Methods and compositions for modulating fertility |
| 05/02/2002 | WO2000042219A9 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| 05/02/2002 | WO1999058683A9 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) |
| 05/02/2002 | US20020053097 Seeds for the generation of crop plants for use in bioremediation, medicine development and making alcoholic beverages |
| 05/02/2002 | US20020053094 Expression of eukaryotic peptides in plant plastids |
| 05/02/2002 | US20020053093 By use of biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 05/02/2002 | US20020053091 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 05/02/2002 | US20020052693 Pharmacophore models for, methods of screening for, and identification of the cytochrome P-450 inhibitory potency of neurokinin-1 receptor antagonists |
| 05/02/2002 | US20020052490 Nucleotide sequences coding polypeptide for use as tool in immunotherapy |
| 05/02/2002 | US20020052489 Nuclear bindng protein for use as tools in controlling gene transcription |
| 05/02/2002 | US20020052488 Replacement polypeptide for use in the treatment of nervous system disorders |
| 05/02/2002 | US20020052487 Transcripts of the MHC class I HLA-G gene and their applications |
| 05/02/2002 | US20020052485 Polynucleotides for use in recombinant adeno-associated virus virion production |
| 05/02/2002 | US20020052483 Intestinal trefoil proteins |
| 05/02/2002 | US20020052481 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4 -IgG2 immunoconjugates, and uses thereof |
| 05/02/2002 | US20020052478 Viricides to control virus replication and delay the onset of HIV-1-related disease symptoms; combined the protease cleavage site residues of the Gag/Gag-Pol precursor proteins and the virion-specific feature of Vpr; DNA construct |
| 05/02/2002 | US20020052477 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
| 05/02/2002 | US20020052476 Nucleotide sequences which code polypeptide for use in treating osteoporosis, tumor metastasis, microbial infections, viral infection, sepsis, inflammation, vision defects, cachicia and muscle disorders |
| 05/02/2002 | US20020052475 Cytokines for use in the treatment of autoimmune disease, inflammation, arthritis and multiple sclerosis |
| 05/02/2002 | US20020052474 Protein for use in the diagnosis and treatment of cell death defects |
| 05/02/2002 | US20020052473 Polypeptide for use as diagnostic tool and in the treatment of sepsis, arthritis, graft versus host disease, and stroke; antiischemic agents |
| 05/02/2002 | US20020052472 ama |
| 05/02/2002 | US20020052471 Human procalcitonin and the preparation and use thereof |
| 05/02/2002 | US20020052469 Amino acid sequences for use in detection and treatment of viral infection |
| 05/02/2002 | US20020052468 Disulfide core polypeptides |
| 05/02/2002 | US20020052415 Treating chronic uremic patients undergoing periodical dialysis |
| 05/02/2002 | US20020052390 Treating non-invasive fungus-induced otitis media by mucoadministering an antifungal agent. |
| 05/02/2002 | US20020052365 Selective anxiolytic therapeutic agents |
| 05/02/2002 | US20020052334 Antisense oligonucleotide, a ribozyme, a protein, a polypeptide, an antibody, or a small molecule. |
| 05/02/2002 | US20020052331 Of a capped target mRNA; oligonucleoides that inhibit protein translation directly via interference with ribosome assembly. |
| 05/02/2002 | US20020052330 Utilizing SBELEVTM polypeptides and polynucleotides in therapy, and diagnostic assays |
| 05/02/2002 | US20020052329 Lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 05/02/2002 | US20020052321 Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof |
| 05/02/2002 | US20020052316 Bax-mediated apoptosis modulating reagents and methods |
| 05/02/2002 | US20020052315 Conformationally constrained backbone cyclized somatostatin analogs |
| 05/02/2002 | US20020052314 Additional smooth muscle relaxant and platelet inhibitory capabilities. |
| 05/02/2002 | US20020052311 Methods and compostions for the treatment and/or diagnosis of neurological diseases and disorders |
| 05/02/2002 | US20020052308 Nucleic acids, proteins and antibodies |
| 05/02/2002 | US20020052047 Nucleotide sequences for use as tools in the generation of disease resistant plants |
| 05/02/2002 | US20020052043 Human G-protein coupled receptors |
| 05/02/2002 | US20020052037 Ribozyme for use as tool in genetic engineering |
| 05/02/2002 | US20020052033 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 05/02/2002 | US20020052030 Nucleotide sequences coding preferential polypeptide for use in treatment of immune defects in animals; for use in veterinary medicine |
| 05/02/2002 | US20020052027 IL-17 homologous polypeptides and therapeutic uses thereof |
| 05/02/2002 | US20020052026 Expressing preferential polypeptides in culture; obtain prokaryotic cells, culture, recover preferential polypeptide |
| 05/02/2002 | US20020052025 RTVP based compositions and methods for the treatment of prostate cancer |
| 05/02/2002 | US20020052024 Nucleotide sequences coding polypeptide for use in treatment of apotosis defects |
| 05/02/2002 | US20020052022 Molecular cloning of a chemokine like 7TMR (AXOR87) |
| 05/02/2002 | US20020052021 Novel G protein-coupled receptors |
| 05/02/2002 | US20020052020 Novel orphan receptors |
| 05/02/2002 | US20020052019 Nucleotide sequences coding membrane protein for use in diagnostic testing and gene therapy |
| 05/02/2002 | US20020052018 Inward rectifier, g-protein activated, mammalian, potassium channels and uses thereof |
| 05/02/2002 | US20020052015 Methuselah gene, compositions and methods of use |
| 05/02/2002 | US20020052013 Tumour-specific P450 protein |
| 05/02/2002 | US20020052012 Method of measuring plasma membrane targeting of GLUT4 |
| 05/02/2002 | US20020052011 Method for evaluating and affecting male fertility |
| 05/02/2002 | US20020052001 Assay |
| 05/02/2002 | US20020051997 Sf, a novel family of taste receptors |
| 05/02/2002 | US20020051996 Modular protein libraries and methods of preparation |
| 05/02/2002 | US20020051993 Nucleotide sequences which code for the RodA protein |
| 05/02/2002 | US20020051988 Inhibition of amyloid protein bnding to neuronal receptor; obtain cell, incubate with modulator, monitor amyloid protein activity |
| 05/02/2002 | US20020051984 Nucleotide sequences coding cell proliferation protein; for use in the treatment of cancer, wounds, inflammation, arthritis, psoraisis, vision and cell proliferation defects |